Direct re-transfusion of autologous blood (ADR) is a technique applied both intra- and postoperatively. Critical assessment reveals that this technique cannot fulfill expectations, particularly with respect to homologous blood avoidance. Undesired compounds delivered with such autologous re-transfusion systems result in – potentially lethal – complications. ADR is rarely indicated, provides blood of low quality, and produces hidden cost.